ORIGINAL ARTICLESClustering of features of von Hippel-Lindau syndrome: evidence for a complex genetic locus
References (25)
- et al.
Lindau disease: review of the literature and study of a large kindred
Am J Med
(1964) - et al.
Proximal 3p deletion in renal cell carcinoma cells from a patient with von Hippel-Lindau disease
Cancer Genet Cytogenet
(1987) - et al.
3p involvement in a renal cell carcinoma in von Hippel-Lindau syndrome: region of tumour breakpoint clustering on 3p?
Cancer Genet Cytogenet
(1988) - et al.
Loss of heterocytogosity on 3p m a von Hippel-Lindau renal cell carcinoma
Cancer Genet Cytogenet
(1989) - et al.
Von Hippel-Lmdau disease affecting 43 members of a single kindred
Medicine
(1989) Basic criteria for clinical diagnosis and genetic counselling in von Hippel-Lindau syndrome
J Vasc Dis
(1987)- Statistische Berichte, herausgegeben vom Statistischen Landesamt Baden-Wurttemberg, Art. Nr. 3122 89001,...
- et al.
Cytogenetic characterization of renal cell carcinoma in von Hippel-Lindau syndrome
Cancer
(1990) - et al.
Cytogenetic studies on three pheochromocytomas derived from patients with von Hippel-Lindau syndrome
Hum Genet
(1989) - et al.
Specific genetic change in tumours associated with von Hippel-Lindau disease
J Natl Cancer Inst
(1989)
Von Hippel-Lindau disease maps to the region of chromosome 3 associated with renal cell carcinoma
Nature
(1988)
Fluorescein angiography in sickle-cell retinopathy and von Hippel-Lindau disease
Int Ophthalmol Clin
(1977)
Cited by (284)
Epidemiology and Economic Burden of von Hippel-Lindau Disease-Associated Renal Cell Carcinoma in the United States
2023, Clinical Genitourinary Cancervon Hippel-Lindau disease: Updated guideline for diagnosis and surveillance
2022, European Journal of Medical GeneticsCitation Excerpt :Supplementary Table 1 gives the frequencies of vHL-associated manifestations, mean ages at manifestation onset, and the frequencies of vHL among patients with the various manifestation types, based on a systematic review of published vHL cohort studies. The prevalence of vHL has been found to be 1:46,900 in Denmark and has internationally been reported to be 1: 36,000–91,000 (Binderup et al., 2016; Evans et al., 2010; Maddock et al., 1996; Maher et al., 1991; Neumann and Wiestler, 1991). No founder effects were identified in the Danish vHL cohort (Binderup et al., 2016).
Retinal angioma of Von hippel-lindau disease: A case report
2022, Annals of Medicine and SurgeryManagement of the patient with incidental bilateral adrenal nodules
2021, Journal of Clinical and Translational Endocrinology: Case ReportsVhl-related neuroendocrine neoplasms and beyond: An Israeli specialized center real-life report
2020, Endocrine Practice
Copyright © 1991 Published by Elsevier Ltd.